Aspartylglucosaminidase (AGA) (Middle Region) Peptid
AGA
Reaktivität: Human
Wirt: Synthetic
BP, WB
-
- Target Alle AGA Produkte
- AGA (Aspartylglucosaminidase (AGA))
- Protein Region
- Middle Region
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB)
- Sequenz
- SMGFINEDLS TTASQALHSD WLARNCQPNY WRNVIPDPSK YCGPYKPPGI
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-AGA Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Aufreinigung
- Purified
-
-
- Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Konzentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handhabung
- Avoid repeated freeze-thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- AGA (Aspartylglucosaminidase (AGA))
- Hintergrund
-
Aspartylglucosaminidase is involved in the catabolism of N-linked oligosaccharides of glycoproteins. It cleaves asparagine from N-acetylglucosamines as one of the final steps in the lysosomal breakdown of glycoproteins. The lysosomal storage disease aspartylglycosaminuria is caused by a deficiency in the AGA enzyme.
Alias Symbols: AGU, ASRG, GA
Protein Interaction Partner: AGA,ALB,IGF2R,AGA
Protein Size: 336 - Molekulargewicht
- 36 kDa
- Gen-ID
- 175
- NCBI Accession
- NM_001171988, NP_001165459
- UniProt
- P20933
-
Sie sind hier:
